Covalis Capital’s Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 AAC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-99,999
Closed -$447K 94
2021
Q4
$447K Hold
99,999
0.16% 58
2021
Q3
$434K Hold
99,999
0.1% 81
2021
Q2
$483K Buy
+99,999
New +$105K 0.16% 79

Other funds holding AAC.WS

Covalis Capital's AAC.WS Position: Q1 2022 in Review

Covalis Capital sold out of Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (AAC.WS) in Q1 2022, closing a stake of 99,999 shares — an estimated $447K sold.

Covalis Capital first reported a position in AAC.WS in Q2 2021 and held it in 3 quarters. The position peaked at $483K in Q2 2021. 86 funds tracked by Wall St. Rank hold AAC.WS as of Q1 2022.

  • Covalis Capital reported no remaining Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q1 2022 after selling out during the quarter.
  • Covalis Capital sold 99,999 Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q1 2022, an estimated $447K.
  • Covalis Capital first reported a position in Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q2 2021 and held it in 3 quarters.
  • Covalis Capital's Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $483K in Q2 2021.
  • 86 funds tracked by Wall St. Rank held Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q1 2022.

Based on Covalis Capital's 13F filing for Q1 2022, filed 16 May 2022.